Compound Summary
Palmitoylethanolamide
Compound Information
Palmitoylethanolamide
Compound Name: | Palmitoylethanolamide |
Compound CID: | 4671 |
Synonyms: | Palmitoylethanolamide Palmidrol 544-31-0 N-(2-Hydroxyethyl)hexadecanamide Impulsin More... |
Iupac Name: | N-(2-hydroxyethyl)hexadecanamide |
InChI: | InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)19-16-17-20/h20H,2-17H2,1H3,(H,19,21) |
InChIKey: | HXYVTAGFYLMHSO-UHFFFAOYSA-N |
Canonical Smiles: | CCCCCCCCCCCCCCCC(=O)NCCO |
Isomeric Smiles: | CCCCCCCCCCCCCCCC(=O)NCCO |
Molecular Weight: | 299.5 |
Molecular Formula: | C18H37NO2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Palmitoylethanolamide
Molecular Weight: | 299.5 |
Molecular Formula: | C18H37NO2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 16 |
Heavy Atom Count: | 21 |
Complexity: | 219 |
Synonyms
Palmitoylethanolamide
| Palmitoylethanolamide | Palmitoylethanolamide |
|---|---|
Palmitoylethanolamide |
Palmidrol |
544-31-0 |
N-(2-Hydroxyethyl)hexadecanamide |
Impulsin |
N-palmitoylethanolamine |
Palmitoyl ethanolamide |
Palmitamide MEA |
Hydroxyethylpalmitamide |
N-(2-Hydroxyethyl)palmitamide |
Palmitoyl-EA |
Loramine P 256 |
Palmitic acid monoethanolamide |
palmitylethanolamide |
Palmidrolum |
HEXADECANAMIDE, N-(2-HYDROXYETHYL)- |
Palmidrol INN |
Monoethanolamine palmitic acid amide |
Anandamide (16:0) |
N-palmitoyl ethanolamine |
Palmitinsaeure-beta-hydroxyethylamid |
UNII-6R8T1UDM3V |
NSC 23320 |
hexadecanoyl ethanolamide |
N-hexadecanoylethanolamine |
N-hexadecanoyl-ethanolamine |
AM 3112 |
6R8T1UDM3V |
CHEBI:71464 |
Palmidrol (INN) |
MFCD00020562 |
NSC-23320 |
NCGC00015793-03 |
AM 3112;Loramine P 256;Mackpeart DR 14V |
DSSTox_CID_22254 |
DSSTox_RID_79975 |
DSSTox_GSID_42254 |
MimyX |
Palmidrolum INN-Latin |
CAS-544-31-0 |
SR-01000076055 |
EINECS 208-867-9 |
N-(2-hydroxyethyl) hexadecanamide |
Hexadecanamide,N-(2-hydroxyethyl)- |
Mackpeart DR 14V |
2-Palmitoylaminoethanol |
Palmdrol prodes (TN) |
Tocris-0879 |
N-hexadecyl-ethanolamine |
Lopac-P-0359 |
Palmitoylethanolamide-d4 |
Palmityoletanolamide (PEA) |
CBiol_002043 |
Lopac0_000905 |
BSPBio_001454 |
KBioGR_000174 |
KBioSS_000174 |
MLS002153421 |
SCHEMBL120518 |
BML2-B10 |
CHEMBL417675 |
GTPL3622 |
DTXSID4042254 |
Palmidrol|N-palmitoylethanolamine |
SCHEMBL19511663 |
BDBM29083 |
KBio2_000174 |
KBio2_002742 |
KBio2_005310 |
KBio3_000347 |
KBio3_000348 |
FSD-201 |
Bio1_000329 |
Bio1_000818 |
Bio1_001307 |
Bio2_000174 |
Bio2_000654 |
HMS1361I16 |
HMS1791I16 |
HMS1989I16 |
HMS2234L19 |
HMS3264C10 |
HMS3266N08 |
HMS3374K03 |
HMS3402I16 |
HMS3411B14 |
HMS3649L03 |
HMS3675B14 |
Pharmakon1600-01506156 |
BCP29005 |
CS-D1253 |
NSC23320 |
ZINC8035017 |
Tox21_110222 |
LMFA08040013 |
NAE(16:0) |
NSC760371 |
s4708 |
STL454872 |
AKOS002676363 |
Tox21_110222_1 |
CCG-204987 |
DB14043 |
LP00905 |
NSC-760371 |
SDCCGSBI-0050880.P002 |
IDI1_033924 |
s10398 |
NCGC00015793-01 |
NCGC00015793-02 |
NCGC00015793-04 |
NCGC00015793-05 |
NCGC00015793-06 |
NCGC00015793-07 |
NCGC00015793-08 |
NCGC00015793-09 |
NCGC00015793-10 |
NCGC00015793-12 |
NCGC00024840-01 |
NCGC00024840-02 |
NCGC00024840-05 |
NCGC00024840-06 |
NCGC00024840-07 |
NCGC00024840-08 |
NCGC00024840-09 |
AS-14094 |
HY-20685 |
SMR000058371 |
Hexadecanoic acid (2-hydroxy-ethyl)-amide |
B6485 |
EU-0100905 |
FT-0778178 |
V1640 |
D08328 |
J90064 |
P 0359 |
AB00918319_06 |
A904411 |
Q2159860 |
SR-01000076055-1 |
SR-01000076055-3 |
SR-01000076055-7 |
BRD-K68095457-001-04-4 |
Z2687203832 |
UNII-3VVG2UI23S component HXYVTAGFYLMHSO-UHFFFAOYSA-N |
UNII-C80684146D component HXYVTAGFYLMHSO-UHFFFAOYSA-N |
Experimental Data
Palmitoylethanolamide
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -8.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Palmitoylethanolamide
Statistics Data
Palmitoylethanolamide
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -8.000000000000000 | 1 | 1 |
Statistics Data Visualization
Palmitoylethanolamide
